With a new CRISPR gene-editing methodology, scientists from the University of Illinois at Urbana-Champaign inactivated one of the genes responsible for an inherited form of amyotrophic lateral sclerosis – a debilitating and fatal neurological disease for which there is no cure. The novel treatment slowed disease progression, improved muscle function and extended lifespan in mice with an aggressive form of ALS.
“ALS unfortunately has few treatment options. This is an important first step in showing that this new form of gene editing could be used to potentially treat the disease,” said bioengineering professor Thomas Gaj, who co-led the study with bioengineering professor Pablo Perez-Pinera.
The method relied on an emerging gene-editing technology known as CRISPR base editors.
Traditional CRISPR gene-editing technologies cut both strands of a DNA molecule, which can introduce a variety of errors in the DNA sequence, limiting its efficiency and potentially leading to a number of unintended mutations in the genome. The Illinois group instead used base editing “to change one letter of the DNA sequence to another without cutting through both DNA strands,” Perez-Pinera said.
“Base editors are too large to be delivered into cells with one of the most promising and successful gene therapy vectors, known as adeno-associated virus,” Gaj said. However, in 2019, Perez-Pinera’s group developed a method of splitting the base editor proteins into halves that can be delivered by two separate AAV particles. Once inside the cell, the halves reassemble into the full-length base editor protein.
By combining the power of AAV gene delivery and split-base editors, Gaj and Perez-Pinera targeted and permanently disabled a mutant SOD1 gene, which is responsible for roughly 20% of inherited forms of ALS. They published their results in the journal Molecular Therapy.
“Many ALS studies are focused on preventing or delaying the onset of the disease. However, in the real world, most patients are not diagnosed until symptoms are advanced,” said graduate student Colin Lim. “Slowing progression, rather than preventing it, may have a greater impact on patients.” Lim is the co-first author of the study along with graduate students Michael Gapinske and Alexandra Brooks.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Lou Gehrig’s disease
- Services Set For Pat Quinn, Co-Founder Of Ice Bucket Challengeon November 27, 2020 at 4:03 pm
Funeral arrangements have been announced for the co-founder of the popular Ice Bucket Challenge. Pat Quinn, a Yonkers resident, died Sunday at the age of 37. Visiting hours will be from 1 p.m. to 8 p.
- Quinn of ALS Ice Bucket Challenge dieson November 24, 2020 at 4:29 am
YONKERS, N.Y. -- A co-founder of the social media ALS Ice Bucket Challenge, which has raised more than $200 million worldwide for Lou Gehrig's disease research, died Sunday at the age of 37, according ...
- Ice Bucket Challenge activist dies aged 37on November 23, 2020 at 2:00 pm
Patrick Quinn, the American man who helped drive the global phenomenon known as the Ice Bucket Challenge to tackle a deadly neuro-degenerative disease, has died aged 37.
- These are the symptoms of ALS disease - as ice bucket challenge co founder dies, aged 37on November 23, 2020 at 8:47 am
Announcing his death the ALS Association credited Mr Quinn, 37, with popularising the craze, noting “the Ice Bucket challenge dramatically accelerated the fight against ALS, lea ...
- ALS disease: the causes and symptoms – as ice bucket challenge co-founder Patrick Quinn dies seven years after diagnosison November 23, 2020 at 8:28 am
Patrick Quinn, the co-creator of the ice-bucket challenge, has died seven years after he was diagnosed with ALS (amyotrophic lateral sclerosis) ...
Go deeper with Google Headlines on:
Lou Gehrig’s disease
Go deeper with Bing News on:
- Will Congress Help This 36-Year-Old ALS Patient Waiting for Access to Experimental Drugs?on November 27, 2020 at 6:11 am
Mayuri Saxena’s only chance to live is through access to experimental drugs. Now Congress holds her fate in its hands.
- Oblio van Lexon genoemd als een van TIME’s 100 beste uitvindingen van 2020on November 26, 2020 at 7:46 am
Annabel [email protected] KEYWORD: FRANCE EUROPE INDUSTRY KEYWORD: PROFESSIONAL SERVICES RETAIL HEALTH FITNESS & NUTRITION SPECIALTY VENTURE CAPITAL SOURCE: Lexon Copyright Business Wire ...
- ALS patients hope Congress can deliver access to potential therapies with bipartisan billon November 25, 2020 at 1:43 pm
While there is no cure and few therapeutics on the market, pharmaceutical companies are developing drugs and therapies that might treat this terminal illness -- and the Accelerating Access to Critical ...
- Pat Quinn, co-founder of ALS Ice Bucket challenge, dies at 37on November 24, 2020 at 5:17 pm
Pat Quinn and co-founder Pete Frates, along with their teams of supporters, helped popularize the challenge. The ALS Association said Quinn “knew it was the key to raising ALS ...
- Ice Bucket Challenge co-founder Pat Quinn has died at age 37 after battle with ALSon November 23, 2020 at 1:44 pm
Pat Quinn, co-founder of the viral ice bucket video challenge, has died at the age of 37 after a seven-year battle with amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease. The ALS ...